Talk To Our Research Analysts: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=219094994

North America dominated the market in 2017

North America accounted for the largest share of the Endoscope Reprocessing Market in 2017, followed by Europe. In the US, the Endoscope Reprocessing Market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the Endoscope Reprocessing Market is driven by the availability of physician bonuses, and implementation of a new funding model for Canadian hospitals.

The various players in the Endoscope Reprocessing Market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.

Browse Related Reports:

Medical Device Cleaning Market by Process (Presoak, Manual Cleaning, Automatic Cleaning, Disinfection) Type (Enzymatic & Non-enzymatic Detergent) Application (Surgical Instruments, Endoscope, Ultrasound Probe) - Global Forecast to 2022

http://www.marketsandmarkets.com/Market-Reports/medical-device-cleaning-market-39633818.html
Infection Control Market by Disinfection Products (Disinfectant, Disinfectors, Endoscope Reprocessors, Wipes, Face Masks), Sterilization Products (Steam Sterilization, Ethylene Oxide, VHP, E-beam, Contract Services), End User (Hospitals, Lifescience) - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html
About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

Endoscopy Homepage